NANOMEDIC EUROPE OÜ - 14111387 | Print Summary Report
STORYBOOK OÜ Tähe 129b, Tartu, 50113 ESTONIA (+372)7446645 info@scorestorybook.ee ssb.ee
[mo_oauth_login]

NANOMEDIC EUROPE OÜ

Summary report

Date of report 12.07.2026

NANOMEDIC EUROPE OÜ

In liquidation
Registration code: 14111387
Founded in: 12.09.2016 (9 years)
EMTAK:

VAT:
EE102431386 (end 21.12.25)
start end
05.11.2021 21.12.2025

Former names

  • Bone Mineral OÜ

Add NANOMEDIC EUROPE OÜ data to your system

Add NANOMEDIC EUROPE OÜ data to your information system with one click or download a CSV file. The data is enriched with direct links to Storybook reports. See also the list of machine-readable data.

keywords

  • lepinguline toitlustusteenus

NANOMEDIC EUROPE OÜ

Scores and ratings

Reputation score

?
What is Reputation score?

Credit Score

?
Risky 0.99

Loader
What is Credit Score?

Open the reports you want to print

Employees and salaries

NANOMEDIC EUROPE OÜ

Number of employees and estimated average salaries
?

NANOMEDIC EUROPE OÜ

Employee taxes and performance analysis
?
QuarterLabor taxes
paid		Number of employees
Turnover
Per Employee		Profit
per employee
2026 I........................
2025 IV........................
2025 III........................
2025 II........................
2025 I........................
2024 IV........................
2024 III........................
2024 II........................
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................
2017 I........................
2016 IV........................
2016 III........................

Deciders and beneficiaries

NANOMEDIC EUROPE OÜ

History of right of representation
?
Field
Catering and Accommodation
Business age
9y
Beneficial country:
Estonia
 
Laura Saar ... - ...
Laura Saar ... - ...
Kairi Kontkar ... - ...
2016
2017
2019
2020
2022
2023
2025
2026
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

NANOMEDIC EUROPE OÜ

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
more_horiz
..................
100%

Former owners

NameCredit ScorePaymentBeginningEnding
more_horiz
..................
more_horiz
..................
more_horiz
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

NANOMEDIC EUROPE OÜ

Taxes paid and estimated average salaries

NANOMEDIC EUROPE OÜ

Quarterly indicators
QuarterTurnoverTaxed turnoverLabour productivityLabour productivityEmployeesNational taxesLabor taxes
2026 I ............ ..............................
2025 IV* ............* ..............................
2025 III* ............* ..............................
2025 II* ............* ..............................
2025 I* ............* ..............................
2024 IV* ............* ..............................
2024 III* ............* ..............................
2024 II* ............* ..............................
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................

NANOMEDIC EUROPE OÜ

Sales revenue by business area

NANOMEDIC EUROPE OÜ

Financial indicators and prognosis

NANOMEDIC EUROPE OÜ

Financial raiting: "SATISFACTORY" (2026 prognosis)
2026 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

NANOMEDIC EUROPE OÜ

Annual reports
Year Period Submitted Report PDF
2024 01.01.2024–31.12.2024 22.05.2025 ......
2023 01.01.2023–31.12.2023 12.07.2024 ......
2022 01.01.2022–31.12.2022 14.12.2023 ......
2021 01.01.2021–31.12.2021 13.12.2023 ......
2020 01.01.2020–31.12.2020 15.07.2021 ......
2019 01.01.2019–31.12.2019 14.07.2021 ......
2018 01.01.2018–31.12.2018 13.07.2021 ......
2017 01.01.2017–31.12.2017 13.07.2021 ......

Liabilities and debts

NANOMEDIC EUROPE OÜ

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

NANOMEDIC EUROPE OÜ

Reports and assets-liabilities overview 12.07.2026
?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

NANOMEDIC EUROPE OÜ

Claims history
?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Creditors' claims ...... €

Total debt claims: ...... €

Latest events
...... ......

NANOMEDIC EUROPE OÜ

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2026 I ...... €...... €...... €...... €......
2025 IV* ...... €...... €...... €...... €......
2025 III* ...... €...... €...... €...... €......
2025 II* ...... €...... €...... €...... €......
2025 I* ...... €...... €...... €...... €......
2024 IV* ...... €...... €...... €...... €......
2024 III* ...... €...... €...... €...... €......
2024 II* ...... €...... €...... €...... €......
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......

NANOMEDIC EUROPE OÜ

Bailiff's enforcement proceedings as of 12.07.2026
?

Bailiff's enforcement proceedings MISSING

NANOMEDIC EUROPE OÜ

Regulations of the Payment Order Department as of 12.07.2026
?

Regulations of the Payment Order Department MISSING

NANOMEDIC EUROPE OÜ

Court orders in the register as of 12.07.2026
?
Logo

Hoiatusmäärus registrist kustutamiseks: majandusaasta aruanne esitamata

11.07.2024

Regulation number: Ä 50036910 / M5

Regulation status has entered into force: 13.07.2024

Date of enforcement of order or additional period: 11.07.2024

Regulation status: Puudused kõrvaldatud

Logo

Hoiatusmäärus registrist kustutamiseks: majandusaasta aruanne esitamata

01.12.2023

Regulation number: Ä 50036910 / M4

Regulation status has entered into force: 01.12.2023

Date of enforcement of order or additional period: 01.12.2023

Regulation status: Jõustunud

Logo

Aruandetrahvimäärus

05.07.2021

Regulation number: Ä 50036910 / M3

Regulation status has entered into force: 26.07.2021

Date of enforcement of order or additional period: 07.10.2021

Regulation status: Jõustunud

Logo

Trahvihoiatusmäärus: majandusaasta aruanne esitamata

19.04.2021

Regulation number: Ä 50036910 / M2

Regulation status has entered into force: 13.07.2021

Date of enforcement of order or additional period: 19.04.2021

Regulation status: Puudused kõrvaldatud

NANOMEDIC EUROPE OÜ

Decisions of the Consumer Disputes Committee as of 12.07.2026
?

Consumer disputes MISSING

NANOMEDIC EUROPE OÜ

Court hearings as of 12.07.2026
?

Court hearings MISSING

NANOMEDIC EUROPE OÜ

Rulings as of 12.07.2026
?

Court settlemets MISSING

NANOMEDIC EUROPE OÜ

Notices and announcements as of 12.07.2026
?
Logo

Notice of liquidation proceedings of a private limited company

26.01.2026
Osaühingu likvideerimismenetluse teade
Avaldamise algus: 26.01.2026
Avaldamise lõpp: tähtajatu

Nanomedic Europe OÜ (registrikood 14111387)xa0(likvideerimisel) likvideerija(d) Laura Saar avaldabxa0teadaande äriseadustiku (ÄS) § 212 lõike 1 alusel.

Võlausaldajatele teatatakse Nanomedic Europe OÜxa0(likvideerimisel)xa0likvideerimismenetlusest.xa0

Võlausaldajatel palume esitada oma nõuded nelja kuu jooksul käesoleva teate avaldamisest (ÄS §xa0212 lg 3).

Ärinimed
Nanomedic Europe OÜ, kehtetud ärinimed: Bone Mineral OÜ.
Nanomedic Europe OÜ
Põhja-Tallinna linnaosa, Tallinn, Harju maakond, Telliskivi tn 60a/9
E-post: laurasaar01@gmail.com
Teadaande number 2554662

Marketing

Business network

NANOMEDIC EUROPE OÜ

 Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

NANOMEDIC EUROPE OÜ

 Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.

We value your privacy

We use cookies to improve your browsing experience, provide personalized ads or content, and analyze our traffic. By clicking "allow all", you agree to our use of all cookies.